We are advancing our mRNA pipelines for the treatment of multiple conditions while working to discover new modalities and programs.

Modality Candidate Gene Targets Indications Discovery Proof-of-Concept Pre-Clinical IND Clinical Trial
mRNA
Therapeutics
PT101 VEGFA Heart Failure and
Vascular-Related
Diseases
PT102 Ras Solid Tumors
PT103 Undisclosed Blood Cancers
PT104 Undisclosed Solid Tumors
mRNA-Engineered
Cell Therapies
PT201 CD19 Blood
Cancers & Autoimmune
Diseases